BAP1 and adenocarcinoma: Loss of BAP1 occurred in four (of 35, 11.4%) thymic carcinomas, including mucoepidermoid carcinoma, undifferentiated carcinoma, adenocarcinoma (Figure 1A–C), and squamous cell carcinoma (n = 1, each).